Prostin VR Pediatric en es it fr

Prostin VR Pediatric Brand names, Prostin VR Pediatric Analogs

Prostin VR Pediatric Brand Names Mixture

  • No information avaliable

Prostin VR Pediatric Chemical_Formula

C20H34O5

Prostin VR Pediatric RX_link

http://www.rxlist.com/cgi/generic/alprostadil.htm

Prostin VR Pediatric fda sheet

Prostin_VR_Pediatric FDA

Prostin VR Pediatric msds (material safety sheet)

Prostin_VR_Pediatric MSDS

Prostin VR Pediatric Synthesis Reference

No information avaliable

Prostin VR Pediatric Molecular Weight

354.481 g/mol

Prostin VR Pediatric Melting Point

115 - 116 oC

Prostin VR Pediatric H2O Solubility

26.7 mg/L

Prostin VR Pediatric State

Solid

Prostin VR Pediatric LogP

2.983

Prostin VR Pediatric Dosage Forms

Liquid; Powder for solution; Solution; Suppository

Prostin VR Pediatric Indication

For palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. Also for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology.

Prostin VR Pediatric Pharmacology

Alprostadil (prostaglandin E1) is produced endogenously to relax vascular smooth muscle and cause vasodilation. In adult males, the vasodilatory effects of alprostadil on the cavernosal arteries and the trabecular smooth muscle of the corpora cavernosa result in rapid arteriolar inflow and expansion of the lacunar spaces within the corpora. As the expanded corporal sinusoids are compressed against the tunica albuginea, venous outflow through the subtunical vessels is impeded and penile rigidity develops. This is referred to as the corporal veno-occlusive mechanism. In infants, the vasodilatory effects of alprostadil increase pulmonary or systemic blood flow.

Prostin VR Pediatric Absorption

The absolute bioavailability of alprostadil has not been determined.

Prostin VR Pediatric side effects and Toxicity

Oral, mouse: LD50 = 186 mg/kg; Oral, rat: LD50 = 228 mg/kg. Apnea, bradycardia, pyrexia, hypotension, and flushing may be signs of drug overdosage.

Prostin VR Pediatric Patient Information

Prostin VR Pediatric Organisms Affected

Humans and other mammals